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Abstract
 
High-affinity antibodies produced by memory B cells differ from antibodies produced in naive
B cells in two respects. First, many of these antibodies show somatic hypermutation, and sec-
ond, the repertoire of antibodies expressed in memory responses is highly selected. To deter-
mine whether somatic hypermutation is responsible for the shift in the antibody repertoire dur-
ing affinity maturation, we analyzed the immunoglobulin lambda light chain (Ig
 
 
 
) repertoire
expressed by naive and antigen-selected memory B cells in humans. We found that the Ig
 
 
 
repertoire differs between naive and memory B cells and that this shift in the repertoire does
not occur in the absence of somatic hypermutation in patients lacking activation-induced cyti-
dine deaminase (AID). Our work suggests that somatic hypermutation makes a significant con-
tribution to shaping the antigen-selected antibody repertoire in humans.
Key words: immunoglobulin repertoire • activation-induced cytidine deaminase • somatic 
hypermutation • memory B cell • afﬁnity maturation
 
Introduction
 
The affinity of antibodies for their cognate antigens in-
creases during immune responses (1). In depth analysis of
hybridoma antibodies specific for influenza hemagglutinin
or for small chemical haptens such as 2-phenyl-5-oxaz-
olone or 4-hydroxy-3-nitrophenyl acetyl (NP) revealed
that somatic hypermutation is one of the mechanisms that
produce this increased affinity (2–9). For example, the
V
 
H
 
186–2 
 
 
 
 Ig
 
 
 
 antibodies dominate the initial antibody
 
response to NP, and mutation from Trp
 
H33
 
 to Leu
 
H33
 
 brings
 
about a 10-fold increase in affinity of these V
 
H
 
186–2 
 
 
 
 Ig
 
 
 
antibodies (8, 10–13). Increased affinity is also accompanied
by a shift in the antibody repertoire, and secondary high-
affinity responses to NP are dominated by Ig
 
 
 
 antibodies
and not Ig
 
 
 
, suggesting that repertoire shifts contribute to
affinity maturation (3, 10, 14, 15). Little is known about
this shift in the repertoire and how it relates to somatic hy-
permutation.
Activation-induced cytidine deaminase (AID) is a germi-
nal center B cell–restricted molecule that carries cytidine
deaminase activity and is required for switch recombination
and somatic hypermutation in mice and humans (16–18).
In the absence of AID, B cells are unable to undergo so-
matic hypermutation or produce secondary antibodies de-
spite germinal center formation (17, 18). Here we report
on the Ig
 
 
 
 antibody repertoire in humans deficient in AID.
We find that AID is essential for the shift in repertoire be-
tween naive and antigen-selected memory B cells.
 
Materials and Methods
 
Patient Samples and Cell Preparation.
 
AID-deficient patients and
 
AID mutations have been described (18). Patients P1, P13,
P14, P17, and P18 were 10, 11, 4, 14, and 2 yr old, respectively
at the time of blood donation, and they did not suffer from
 
chronic infections. They were treated with intravenous Ig sup-
plementation. Control donors C1, C2, C3, C4, C5, C6, and C7
were healthy and 32, 11, 35, 2, 28, 41, and 33 yr old, respectively
when blood samples were obtained. Blood mononuclear cells
 
were isolated on Ficoll gradients. Control CD19
 
 
 
 B cells
were fractionated into naive CD19
 
 
 
IgM
 
 
 
CD27
 
 
 
 and memory
CD19
 
 
 
IgM
 
 
 
CD27
 
 
 
 B cells by cell sorting on FACS Vantage™.
Due to absence of secondary isotypes in AID-deficient patients,
AID B cells are all IgM
 
 
 
 and were therefore sorted into naive
CD19
 
 
 
CD27
 
 
 
 and memory CD19
 
 
 
CD27
 
 
 
 B cells without IgM
staining. Antibodies used for staining were FITC–anti-CD19,
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PE–anti-CD27 (Immunotech/Beckman Coulter), and biotin-
conjugated anti-IgM mAb (PharMingen), which was visualized
with Streptavidin Red 670 (GIBCO BRL).
 
Reverse Transcription PCR, Cloning, and Sequencing.
 
Total RNA
was extracted from 10
 
4
 
–10
 
5
 
 purified cells using TRIzol Re-
agent (GIBCO BRL) and reverse transcribed in a 10-
 
 
 
l reac-
tion with Superscript II (GIBCO BRL). For reverse transcription
(RT)-PCR reactions, 1 
 
 
 
l of cDNA was amplified for 30–35 cy-
cles of 30 s at 94
 
 
 
C, 30 s at 58
 
 
 
C (V
 
H
 
1-C
 
 
 
) or at 55
 
 
 
C (V
 
 
 
-C
 
 
 
)
and 30 s at 72
 
 
 
C with a final 10-min extension at 72
 
 
 
C using
HotStarTaq™ DNA polymerase (QIAGEN) and the following
primers: V
 
 
 
1
 
 
 
8 family consensus sense, 5
 
 
 
-GGG(G/A)TC(T/
C)CTGA(C/T/G)CG(A/C/G)TTCTCTGG(C/G)TCC-3
 
 
 
;
V
 
 
 
9 sense, 5
 
 
 
-ATCCCTGATCGCTTCTCAGTCTTG-3
 
 
 
;
V
 
 
 
10 sense, 5
 
 
 
-GATCTCAGAGAGATTATCTGCATCC-3
 
 
 
;
and C
 
 
 
 antisense, 5
 
 
 
-CACAC(T/C)AGTGTGGCCTTGTTG-
GCTTG-3
 
 
 
. Sense FR1 V
 
H
 
1 and antisense C
 
 
 
 primers were as
described previously (19, 20). RT-PCR products were run on
2% agarose gels, and PCR products were gel purified
(Qiaquick™; QIAGEN) and cloned into TA vectors (Invitro-
gen). Double-stranded DNA sequences were obtained using anti-
sense C
 
 
 
 or C
 
 
 
 primers and Dye Terminator Cycle Sequencing
(PE Applied Biosystems). Sequences were analyzed using Ig
BLAST
 
®
 
. When two or more identical sequences were found,
they were counted as a single clone. Sequences were considered
mutated when they displayed two or more nucleotide differences
from their germline counterparts. Differences in gene distribution
between naive and memory B cells were analyzed with chi-
square tests (Cochran-Mantel-Haenszel test) adjusted by the
Bonferroni method for multiple testing and they were considered
significant when 
 
P
 
 values were equal to or less than 0.05.
 
Results and Discussion
 
To determine whether there is a shift in repertoire be-
tween naive and antigen-selected B cell compartments in
humans, we compared the unmutated germline Ig
 
 
 
 se-
quences to mutated Ig
 
 
 
 sequences obtained from CD19
 
 
 
peripheral B cells from four control donors. In humans, Ig
 
 
 
light chains are found in 30–40% of all antibodies, and
among the 10 V
 
 
 
 gene families three (V
 
 
 
1, V
 
 
 
2 and V
 
 
 
3)
represent 
 
 
 
80–90% of all V
 
 
 
 genes (21, 22). We found
that the distribution of V
 
 
 
1 and V
 
 
 
2, two of the most fre-
quently used human V
 
 
 
 families, differs between germline-
encoded and mutated antibodies (Fig. 1 A; total of 239 in-
dividual sequences): V
 
 
 
1 is decreased and V
 
 
 
2 increased
Figure 1. Ig  repertoire expressed in peripheral B cells from control
donors. (A) V 1 and V 2 gene usage in germline-encoded (open bars)
and mutated (solid bars) sequences from CD19  peripheral B cells in four
unrelated controls. 25, 15, 46, and 34 germline V J  sequences from do-
nors C1, C2, C3, and C4 were compared with 33, 23, 33, and 29 mu-
tated V J  sequences from the same individuals. The percent V  utiliza-
tion is indicated on the y axis. (B) Combined total of V 1 and V 2 gene
usage in germline and mutated V J  sequences from control donors. 121
germline-encoded and 118 mutated sequences were obtained from the
four control donors. Asterisk (*) indicates statistically significant difference
(V 1, P   0.022; V 2, P   0.0004).
Figure 2. Ig  repertoire ex-
pressed in naive and memory B
cells from control donors. (A)
V 1 and V 2 gene usage in
naive CD19 IgM CD27 
(open bars) and memory
CD19 IgM CD27  (solid bars)
B cells in three unrelated con-
trols. 33, 33, and 52 V J  se-
quences from naive B cells from
donors C5, C6, and C7, respec-
tively were compared with 39,
42, and 63 V J  sequences from
memory B cells from the same
individuals. The percent V  utili-
zation is indicated on the y axis.
(B) Combined total V 1 and
V 2 gene usage in CD19 
IgM CD27  and CD19 IgM 
CD27  B cells. Asterisk (*) indi-
cates statistically significant dif-
ference (V 1,  P    0.035; and
V 2, P   0.0017).377 Meffre et al. Brief Definitive Report
among mutated Ig s, and this difference is independent of
the age of the donors (Fig. 1, A and B).
To further analyze the shift in Ig  repertoire between
naive and memory B cells, we fractionated peripheral B
cells using CD27 memory marker and isolated naive
(CD19 IgM CD27 ) and memory (CD19 IgM CD27 )
B cells from control donors (23, 24). The difference in V 
distribution was also found when comparing naive and
memory B cell compartments (Fig. 2; total of 262 se-
quences). Antibodies cloned from memory B cells were
predominantly mutated and showed decreased V 1 and in-
creased V 2 gene usage (Fig. 2, A and B). We conclude that
there is a shift in the Ig  repertoire between the naive and
antigen-selected memory B cell compartments in humans.
To determine whether the shift in Ig  repertoire be-
tween the naive and memory compartments is related to
somatic hypermutation, we analyzed the Ig  genes ex-
pressed in naive and memory B cells from patients lacking
activation-induced deaminase (AID) (17, 18). AID has
been shown to be essential for both hypermutation and
switch recombination but does not appear to be necessary
for normal B cell development in mice and humans (17,
18). Patients with AID deficiency showed no secondary
antibodies and no somatic mutation; nevertheless, these in-
dividuals displayed enlarged tonsils with germinal centers
and showed normal numbers of CD19 CD27  B cells
(18). The CD27 IgM  B cells found in AID-deficient pa-
tients resembled authentic CD27 IgM  memory B cells in
that they showed normal selection against VH1–69, a VH
gene that is frequently found in B lymphoid chronic lym-
phocytic leukemias producing autoreactive antibodies (Fig.
3) (19, 25, 26). However, the antibodies expressed in anti-
gen-selected memory B cells in five AID-deficient patients
differed from the three controls in that they showed no
mutations, and there was no shift in the V  repertoire be-
tween naive B cells and antigen-selected memory B cells
(compare Figs. 2 and 4; total of 330 sequences). In particu-
lar, there was no increase in V 2 gene expression and no
relative decrease in V 1 (Fig. 4). In addition, VH5–51 gene
usage was favored in the memory CD27  B cells from
AID-deficient patients but not in normal controls (Fig. 3).
Somatic hypermutation is known to increase antibody
affinity during immune responses. However, the contribu-
tion of mutation to shaping the antibody repertoire has not
been determined. We have found a global shift in the Ig 
Figure 3. VH1 and VH5 repertoire analysis of naive and memory B cells
from control donors and AID-deficient patients. 77 control C5, C6, and
C7 (top) and 105 AID (bottom) VH1 and VH5 sequences from naive B
cells (open bars) are compared with 58 control and 112 AID sequences
from memory B cells (solid bars). The percent VH1 and VH5 utilization is
indicated on the y axis. Asterisk (*) indicates statistically significant differ-
ence (VH1–69, P   0.0001 for both controls and AID-deficient patients;
VH5–51, P   0.03 for AID-deficient patients).
Figure 4. V 1 and V 2 gene
usage in naive and memory B
cells from AID-deficient pa-
tients. (A) V 1 and V 2 gene
usage in naive CD19 CD27 
(open bars) and memory
CD19 CD27  (solid bars) B
cells in five unrelated AID-defi-
cient patients. The patient num-
bers are as described in reference
18. 34, 30, 31, 35, and 31 V J 
sequences from naive B cells
from AID-deficient patients P1,
P13, P14, P17, and P18, respectively were compared with 31, 35, 32, 37,
and 34 V J  sequences from memory B cells from the same individuals.
The percent V  utilization is indicated on the y axis. (B) Combined total
V 1 and V 2 gene usage in CD19 CD27  and CD19 CD27  B cells
for AID-deficient patients.378 Human Ig  Memory B Cell Repertoire Is Shaped by Somatic Hypermutation
antibody repertoire between naive and memory B cells
from normal donors. This shift in repertoire is associated
with somatic hypermutation and is AID dependent. We
conclude that AID and hypermutation make a significant
contribution to shaping the antigen-selected memory B cell
repertoire in humans.
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